Skip to main content

2024 National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Scientific/Medical - Research

Individual Awards

For discovery of the pathogenic role of peripherally-acting endocannabinoids in metabolic syndrome and introducing the first peripheral CB1 receptor antagonist for treatment of this disorder.

  • George Kunos, NIAAA

Recognition Across NIH

The following individuals are recognized as part of a group hosted by another IC.

OD

  • F.L. Dammann, NIAAA